โ€˜Itโ€™s a new market for ubiquinolโ€™: Study highlights CoQ10 formโ€™s menopause benefits

With chemical structure 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone, CoQ10 is also known as ubiquinone because of its ‘ubiquitous’ distribution throughout the human body. Kanekaโ€™s ubiquinol is the reduced form of the ingredient and has been shown to have higher bioavailability than ubiquinoneโ€‹.

CoQ10 plays a vital role in the production of chemical energy in mitochondriaโ€”the ‘power plants’ of the cellโ€” by participating in the production of adenosince triphosphate (ATP), the body’s co-called ‘energy currency’. While humans can synthesise CoQ10, the levels decline as we age.

There is a significant body of scientific data supporting CoQ10โ€™s role in cognitive health, heart health and anti-ageing. The nutrient is also recommended to people on statins to off-set the CoQ10-depleting effects of the medication.

A 2008 study in the journal BioFactorsโ€‹โ€‹ also reported that hormone replacement therapy (HRT) can decrease serum concentrations of CoQ10, indicating a role specifically for womenโ€™s health. ย 

The womenโ€™s health opportunityโ€‹

This has now been supported by new data from a study performed by French research institute Expansion Consulteam earlier this year in collaboration with French lifestyle influencers Virginie Florin and Nathalie Simon.

Two hundred female participants between the ages of 45 and 55 were recruited following an Instagram live stream. The women were asked to take a 200 mg/day dosage of Kaneka Ubiquinol for two months. They were then asked to monitor the effects and report back on their observations before, during and after the supplementation period.



Source link


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

>